Karyopharm Therapeutics (KPTI) Shares Outstanding (Diluted) (2020 - 2026)
Karyopharm Therapeutics' Shares Outstanding (Diluted) came in at 28.94 million for Q2 2026, up 235.7% from 8.62 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025, Karyopharm Therapeutics' Shares Outstanding (Diluted) was 10.94 million, up 29.3% from FY2024.
- Shares Outstanding (Diluted) has increased in each of the last five years, with a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Diluted) was 8.45 million in FY2024 (+11.0%), 7.62 million in FY2023 (+39.5%), 5.46 million in FY2022 (+8.8%) and 5.01 million in FY2021 (+4.4%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2020.
- Year-over-year, Shares Outstanding (Diluted) increased in six of the last seven quarters, with growth averaging 40.4%.
- The fastest year-over-year change in Shares Outstanding (Diluted) over five years came in Q2 2026 (growth of 235.7%), and the weakest in Q2 2025 (a decline of 16.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Karyopharm Therapeutics | 25.18 Mn | -201.25 Mn | 32.35 Mn | 28.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.94 Mn |
| Dec 31, 2025 | 10.94 Mn |
| Sep 30, 2025 | 8.67 Mn |
| Jun 30, 2025 | 8.62 Mn |
| Mar 31, 2025 | 8.47 Mn |
| Dec 31, 2024 | 8.45 Mn |
| Sep 30, 2024 | 8.33 Mn |
| Jun 30, 2024 | 10.30 Mn |
| Mar 31, 2024 | 7.70 Mn |
| Dec 31, 2023 | 7.62 Mn |
| Sep 30, 2023 | 7.63 Mn |
| Jun 30, 2023 | 7.61 Mn |
| Mar 31, 2023 | 7.57 Mn |
| Dec 31, 2022 | 5.46 Mn |
| Sep 30, 2022 | 5.35 Mn |
| Jun 30, 2022 | 5.31 Mn |
| Mar 31, 2022 | 5.17 Mn |
| Dec 31, 2021 | 5.01 Mn |
| Sep 30, 2021 | 5.03 Mn |
| Jun 30, 2021 | 5.01 Mn |
API Access
Karyopharm Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();